Dipperam 5 mg/160 mg filmom obložene tablete
| Name | Dipperam 5 mg/160 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-273437554 |
| Active Substance | amlodipinbesilat valsartan |
| Composition | svaka filmom obložena tableta sadrži 5 mg amlodipina (u obliku amlodipinbesilata) i 160 mg valsartana |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Novartis Pharma GmbH, Nürnberg, Njemačka
Novartis Farma S.p.A., Torre Annunziata (Napulj), Italija Novartis Farmacéutica S.A., Barcelona, Španjolska |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 14.06.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/152 |
| Registration Number | 381-12-01/70-22-02 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09DB01 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
